VVZ API is not affiliated with ETH Zurich. Data might be outdated or incorrect. Please view the official ETHZ Vorlesungsverzeichnis for binding information.

535-0050-00L 2 Credits MSC D-CHAB
You're viewing possible stale or outdated data. Please check the latest semester for more up-to-date information.

Pharmacoepidemiology and Evidence Based Medicine

Pharmacoepidemiology / Evidence-based Medicine

Lecturers & Examiners: Katharina Hartmann
VVZ CR n/a

Last Updated: 2026-02-05 15:05:21

Abstract

Introduction of principles of pharmacoepidemiology and epidemdiology in addressing drug related questions in the population and of epidemiologic perspectives for health care managementIn parallel appropriate tools to critique pharmacoepidemiologic studies in medical literature will be given and applied.

Objective

Objectives: To familiarize participants with the principles of pharmacoepidemiology and epidemiology in addressing drug related questions with concern to the use, effects and risks of medicinal products in a large population. To introduce participants to fundamental statistical, economic and epidemiological concepts and methods. To provide the appropriate tools to critique pharmacoepidemiologic studies in the literature and to critically read and understand papers in the medical literature which relate to drug benefits, risks, and costs. To address controversial topics in drug use and benefit-risk assessment, and to critically appraise the outcome of drug therapy. To equip participants with skills to facilitate further studies in these areas.

Content

The contribution of epidemiology to the study of drug uses, effects and risks: - Pharmacoepidemiology study methodologies, concepts and strategies, - Detection and identification of uninteded drug effects (pharmacovigilance), - Quantifying uninteded effects and drug interactions, - Pharmacogenetic and biologic markers of unintended drug effects, - Bias and confounding by indication, - Drug utilization - Large automated databases and propensity scores. Pharmacoepidemiology and outcome assessment of drug therapy. Meta-analysis in pharmacoepidemiology. Pharmacoepidemiology and regulatory decision making in drug safety.

Resources

Lecture Notes

This course will be a combination of formal lectures, group discussions and self-directed project work. Course material will be taught through seminars, case studies and group projects. Reading material and scripts will be given for each week.

Literature

A reading list pertinent to the course will be provided during the course. Methodological referen Strom B; Pharmacoepidemiology, 3rd ed. Wiley, Chichester, 2000 Rothman K, Greenland S; Modern Epidemiology, 2nd ed. Lippincott, Philadelphia, 1998 Mann R, Andrews E: Pharmacovigilance, Wiley, Chichester, 2003

General Information

Language
German
Levels
MSC
Frequency
Yearly recurring

Examination

Type
session examination
Mode
written 60 minutes
Aids
None

Course Components

Type Title Time & Place Hours
lecture with exercise Pharmacoepidemiology / Evidence-based Medicine
  • Fri 07:45-11:30 (HPT C 103)
2 h weekly

Offered In